Nuage Therapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
24
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$3.12M
- Investors
-
6
Nuage Therapeutics General Information
Description
Developer of selective and potent drugs designed for intrinsically disordered targets. The company leverages proprietary assays to discover new drugs for the treatment of castration-resistant prostate cancer, biomolecular condensation, and chemical biology to develop selective inhibitors of intrinsically disordered proteins, enabling doctors to treat undruggable proteins involved in diseases with unmet medical needs.
Contact Information
Website
www.nuagetx.comCorporate Office
- Parc Científic de Barcelona
- C/Baldiri Reixac 10-12 (Torre I)
- 08028 Barcelona
- Spain
Corporate Office
- Parc Científic de Barcelona
- C/Baldiri Reixac 10-12 (Torre I)
- 08028 Barcelona
- Spain
Nuage Therapeutics Timeline
Nuage Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Grant | 02-Dec-2025 | $3.12M | Completed | Startup | ||
| 4. Early Stage VC | 28-May-2025 | Completed | Startup | |||
| 3. Accelerator/Incubator | 21-Feb-2025 | Completed | Startup | |||
| 2. Seed Round | 20-Jun-2023 | $12.9M | $18.4M | Completed | Startup | |
| 1. Seed Round | 28-Sep-2021 | $5.42M | $5.42M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Nuage Therapeutics Comparisons
Industry
Financing
Details
Nuage Therapeutics Competitors (68)
One of Nuage Therapeutics’s 68 competitors is Adimab, a Venture Capital-Backed company based in Lebanon, NH.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Adimab | Venture Capital-Backed | Lebanon, NH | ||||
| CellCentric | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| Noveome Biotherapeutics | Venture Capital-Backed | Pittsburgh, PA | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| Baliopharm | Venture Capital-Backed | Basel, Switzerland |
Nuage Therapeutics Signals
Nuage Therapeutics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Agency State of Investigation | Government | |||
| BCN Health Booster | Accelerator/Incubator | Minority | ||
| BStartup10 | Corporate Venture Capital | Minority | ||
| CDTI Innvierte | Government | Minority | ||
| Sofinnova Partners | Venture Capital | Minority |
Nuage Therapeutics FAQs
-
When was Nuage Therapeutics founded?
Nuage Therapeutics was founded in 2021.
-
Where is Nuage Therapeutics headquartered?
Nuage Therapeutics is headquartered in Barcelona, Spain.
-
What is the size of Nuage Therapeutics?
Nuage Therapeutics has 24 total employees.
-
What industry is Nuage Therapeutics in?
Nuage Therapeutics’s primary industry is Drug Discovery.
-
Is Nuage Therapeutics a private or public company?
Nuage Therapeutics is a Private company.
-
What is Nuage Therapeutics’s current revenue?
The current revenue for Nuage Therapeutics is .
-
How much funding has Nuage Therapeutics raised over time?
Nuage Therapeutics has raised $20.4M.
-
Who are Nuage Therapeutics’s investors?
Agency State of Investigation, BCN Health Booster, BStartup10, CDTI Innvierte, and Sofinnova Partners are 5 of 6 investors who have invested in Nuage Therapeutics.
-
Who are Nuage Therapeutics’s competitors?
Adimab, CellCentric, Noveome Biotherapeutics, Inovio Pharmaceuticals, and Baliopharm are some of the 68 competitors of Nuage Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process